It was another busy week for Australia's top brokers. This led to the release of a large number of broker notes.
Three ASX broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
CSL Limited (ASX: CSL)
According to a note out of UBS, its analysts have initiated coverage on this biotherapeutics giant's shares with a buy rating and $330.00 price target. UBS feels that CSL is well-positioned for growth thanks to tailwinds across all its businesses. Together with its development pipeline, the broker suspects the company could outperform consensus expectations in the coming years. The CSL share price ended the week at $304.18.
NIB Holdings Limited (ASX: NHF)
A note out of Goldman Sachs reveals that its analysts have initiated coverage on this private health insurer's shares with a buy rating and $8.80 price target. Goldman likes NIB due to its belief that it has stronger Australian resident health insurance underlying top line growth potential than its key rival. The broker also highlights that NIB is taking more shareholder-friendly action to not profit from Covid-19, which is resulting in better reported margins. The NIB share price was fetching $8.22 on Friday.
Treasury Wine Estates Ltd (ASX: TWE)
Analysts at Goldman Sachs have also reiterated their buy rating on this wine giant's shares with a trimmed $14.20 price target. Although the broker was a touch disappointed with the company's FY 2023 guidance, it believes the selloff has created a very attractive buying opportunity for investors. Particularly given the quality of the company and its long-term moat. The Treasury Wine share price ended the week at $11.76.
